.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Sanofi plans to buy Vigil Neuroscience, a drugmaker advancing TREM2 agonism prog...
The FDA’s Oncologic Drugs Advisory Committee voted 8-0 against a new indication ...
Hinge Health priced its shares at $32 per share, valuing the virtual physical th...
The FDA has asked for two Covid-19 vaccines made by Moderna and Pfizer/BioNTech ...
The FDA said it is making “enhancements” designed to help states develop program...
The FTC is continuing its campaign against drug patents that it claims are impro...
Eikon Therapeutics is laying off staff for the second time in 19 months, respond...
The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against U...
BioNTech is spending up to £1 billion over the next ten years to boost its R&D a...
For some biotechs, the office is a place where scientists gather and pipelines a...
Plus, news about Genfit, Ipsen, Accropeutics, Merck KGaA, Alumis and Acelyrin: ...
Scientists from Weill Cornell Medicine in New York have announced the results fr...
Roche’s subsidiary Genentech is signing a second deal with Orionis Biosciences t...
PureTech Health’s tweaked form of Roche’s lung fibrosis drug Esbriet slowed lung...
Altos Labs, the massive but still relatively secretive $3 billion biotech, has f...